Terman D S, Tavel T, Petty D, Racic M R, Buffaloe G
Clin Exp Immunol. 1977 Apr;28(1):180-8.
Studies were undertaken to determine whether BSA immobilized in collodion membranes adherent to activated charcoal particles, would be capable of specifically removing circulating BSA antibody in vitro and in vivo in an extracorporeal system in dogs. Up to 59-8 mg of BSA were retained in collodion membranes adherent to small particles. In vitro studies demonstrated that immobilized BSA could specifically reduce BSA binding activity from circulating antisera. For in vivo studies, an extracorporeal circulation system was established and arterial blood was circualted through a continuous flow celltrifuge in which plasma was separated from formed elements of the blood. Only plasma was circulated over the BSA collodion-charcoal immunoadsorbent. Anti-BSA and anti-HSA atibodies were passively infused into dogs and, after an equlibration period of 12 or 15 min, plasma was passed over the BSA collodion-charcoal immunoadsorben. Plasma exhibited a sharp reduction in BSA binding over the next 30-60 min with only slight reduction in anti-HSA binding the same period. Dogs, actively immunized to BSA and HSA, were also treated by extracorporeal plasma perfusion over BSA collodion-charcoal. A specific decline in BSA binding of sera, was again observed with minimal changes in HSA binding. A post-perfusion rebound of BSA binding was observed which reached pre-perfusion levels after 6-8 days. A second treatment during the rebound period also resulted in a specific decline in BSA binding with a similar pattern of antibody rebound. There were no significant changes in I-labelled BSA recorded on the charcoal before and after in vivo procedures and no signifcant alterations in haematocrit, serum sodium, potassium, calcium, magnesium or creatinine levels before and after the procedures. These data suggests that antigen-coated charcoal may specifically withdraw circulating antibodies in vivo with minimal release of the entrapped antigen and little alteration in the host's haematological and biochemical status.
开展了多项研究,以确定固定在附着于活性炭颗粒的火棉胶膜中的牛血清白蛋白(BSA),是否能够在体外以及犬类体外系统的体内特异性去除循环中的BSA抗体。附着于小颗粒的火棉胶膜中保留了高达59.8毫克的BSA。体外研究表明,固定的BSA可特异性降低循环抗血清中的BSA结合活性。对于体内研究,建立了体外循环系统,动脉血通过连续流动细胞离心机循环,在该离心机中血浆与血液中的有形成分分离。只有血浆在BSA火棉胶 - 活性炭免疫吸附剂上循环。将抗BSA和抗HSA抗体被动注入犬体内,在12或15分钟的平衡期后,使血浆通过BSA火棉胶 - 活性炭免疫吸附剂。在接下来的30 - 60分钟内,血浆中的BSA结合显著降低,而同期抗HSA结合仅有轻微降低。对BSA和HSA进行主动免疫的犬,也通过在BSA火棉胶 - 活性炭上进行体外血浆灌注来治疗。再次观察到血清中BSA结合特异性下降,而HSA结合变化最小。观察到灌注后BSA结合有反弹,在6 - 8天后达到灌注前水平。在反弹期进行的第二次治疗也导致BSA结合特异性下降,并伴有类似的抗体反弹模式。体内操作前后,活性炭上记录的碘标记BSA没有显著变化,操作前后血细胞比容、血清钠、钾、钙、镁或肌酐水平也没有显著改变。这些数据表明,抗原包被的活性炭在体内可能特异性去除循环抗体,同时截留的抗原释放极少,并且宿主的血液学和生化状态几乎没有改变。